In Silico Approach to Investigate the Structural and Functional Attributes of Familial Hypercholesterolemia Variants Reported in the Saudi Population
- PMID: 29172679
- DOI: 10.1089/cmb.2017.0018
In Silico Approach to Investigate the Structural and Functional Attributes of Familial Hypercholesterolemia Variants Reported in the Saudi Population
Abstract
Familial hypercholesterolemia (FH) is a metabolic disorder that leads primarily to premature cardiovascular diseases, the main cause of mortality in Saudi Arabia (SA). FH is underreported and underdiagnosed in SA with statistical evidence of high expected prevalence in such a consanguineous community. Lacking knowledge of which and how these alterations are actually impacting lipid metabolism is one of the main reasons why FH is insufficiently diagnosed in the region. The aim of this study was to develop a fast prediction approach using an integrated bioinformatics method for future screening of the potential causative variants from national registries. A total of 21 variants were detected with majority rate in LDLR (81%). Variants were classified based on the type of mutation. Missense variants resulting in amino acid changes, c.1429G>A (p.D477N), c.1474G>A (p.D492N), c.1731G>T (p.W577C), and c.1783C>T (p.R595W) in LDLR gene, in addition to c.9835A>G (p.S3279G) in APOB, were shown to be deleterious by concordant analysis. Furthermore, functional interaction deformities showed a significant loss and gain of energies in the mutated proteins. These findings will help in distinguishing the most harmful mutations needed to be screened for clinically diagnosed FH patients in SA. Such computational research is necessary to avoid time consumption and the usage of expensive biological experiments. This can be a fast track to facilitate the future filtering and screening of causative mutations from national registries.
Keywords: bioinformatic; computational analysis; familial hypercholesterolemia; in silico; mutation.
Similar articles
-
Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.Curr Vasc Pharmacol. 2022;20(4):361-369. doi: 10.2174/1570161120666220304101606. Curr Vasc Pharmacol. 2022. PMID: 35249492
-
Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.Atherosclerosis. 2019 Feb;281:1-8. doi: 10.1016/j.atherosclerosis.2018.12.003. Epub 2018 Dec 15. Atherosclerosis. 2019. PMID: 30583242
-
Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.Panminerva Med. 2023 Dec;65(4):479-490. doi: 10.23736/S0031-0808.22.04612-2. Epub 2022 Mar 11. Panminerva Med. 2023. PMID: 35274909
-
Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants.Int J Mol Sci. 2018 Jun 5;19(6):1676. doi: 10.3390/ijms19061676. Int J Mol Sci. 2018. PMID: 29874871 Free PMC article. Review.
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
Cited by
-
Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.Life (Basel). 2023 Jul 11;13(7):1542. doi: 10.3390/life13071542. Life (Basel). 2023. PMID: 37511917 Free PMC article.
-
Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations.Front Med (Lausanne). 2023 Jan 10;9:1090120. doi: 10.3389/fmed.2022.1090120. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36703890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
